The Ensign Group (ENSG)
(Delayed Data from NSDQ)
$148.43 USD
-0.61 (-0.41%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $148.38 -0.05 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$148.43 USD
-0.61 (-0.41%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $148.38 -0.05 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum B VGM
Zacks News
Ensign Group's (ENSG) Q2 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) Q2 earnings results reflect better revenues from its Transitional and Skilled Services segment.
Ensign Group (ENSG) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 36.84% and 2.00%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Ensign Group (ENSG) to Report Q2 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
Ensign Group (ENSG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ensign Group (ENSG) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Ensign Group (ENSG) closed the most recent trading day at $42.52, moving +1.6% from the previous trading session.
Ensign Group (ENSG) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Ensign Group (ENSG) closed at $40.90, marking a +1.26% move from the previous day.
Ensign Group (ENSG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Ensign Group (ENSG) closed the most recent trading day at $42.20, moving -1.01% from the previous trading session.
Ensign Group (ENSG) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Ensign Group (ENSG) closed at $41.99, marking a +1.18% move from the previous day.
Here's Why You Should Add Ensign Group to Your Portfolio
by Zacks Equity Research
Strategic initiatives and a healthy balance sheet make Ensign Group (ENSG) an attractive pick for investors.
Why Is Ensign Group (ENSG) Up 22.4% Since Last Earnings Report?
by Zacks Equity Research
Ensign Group (ENSG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top ETFs & Stocks From Top-Ranked Sectors
by Sweta Killa
Investors could be well served by ETFs and stocks from sectors that house top-ranked industries.
Acadia Healthcare Ties Up for Improved Behavioral Services
by Zacks Equity Research
Acadia Healthcare (ACHC) partners with Covenant Health for offering improved mental health services in East Tennessee.
Humana Contract Renewal to Aid Medicaid Members in Kentucky
by Zacks Equity Research
Humana's (HUM) new agreement intends to efficiently serve Medicaid members of Kentucky, where it already boasts of a strong base.
Has The Ensign Group (ENSG) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (ENSG) Outperforming Other Medical Stocks This Year?
The Zacks Analyst Blog Highlights: Brookdale Senior Living, The Ensign Group, Amedysis and Chemed
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Brookdale Senior Living, The Ensign Group, Amedysis and Chemed
Silver Tsunami to Hit the United States: 4 Stocks in Focus
by Aparajita Dutta
There are approximately 35 million Americans aged 65 or older currently and this number is expected to double in the next 25 years.
UnitedHealthcare Ties Up to Improve Eye Health of Members
by Zacks Equity Research
UnitedHealth Group's (UNH) UnitedHealthcare business collaborates with GlassesUSA.com for providing improved eye care to its eligible members.
MEDNAX Affiliate Ties Up With CDI to Improve Patient Care
by Zacks Equity Research
MEDNAX's (MD) affiliate Jefferson Radiology collaborates with CDI for providing enhanced healthcare services to the Springfield community.
Ensign Group's (ENSG) Q1 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) first-quarter 2020 results reflect strong revenues courtesy of robust segmental performance, partly offset by high costs.
Ensign Group (ENSG) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 24.19% and 1.91%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Ensign Group (ENSG) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Ensign Group (ENSG) closed the most recent trading day at $34.41, moving +1.87% from the previous trading session.
What's in Store for Ensign Group's (ENSG) Earnings in Q1?
by Zacks Equity Research
Ensign Group's (ENSG) Q1 results are likely to reflect a better revenue stream.
3 Undervalued Zacks Rank #1s
by James Giaquinto
3 Undervalued Zacks Rank #1s
Here is Why Growth Investors Should Buy Ensign Group (ENSG) Now
by Zacks Equity Research
Ensign Group (ENSG) could produce exceptional returns because of its solid growth attributes.
Ensign Group (ENSG) to Report Q1 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
Ensign Group (ENSG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Coronavirus Ravages US Employment Boom: 5 Safe Stocks to Buy
by Sreoshi Bera
Surge in jobless claims for four consecutive weeks calls for investment in these five recession-proof stocks.